Showing results (871-880 of 960) with videos related to
Sort By:
Pageof 96
Immunity|November 3, 2015
The PIAS-like Coactivator Zmiz1 Is a Direct and Selective Cofactor of Notch1 in T Cell Development and LeukemiaNancy Pinnell, Ran Yan, Hyo Je Cho, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|January 2, 2010
Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imagingSteven K Engle, Philip F Solter, Kelly M Credille, et al.European Journal of Immunology|February 12, 2020
CD96 functions as a co-stimulatory receptor to enhance CD8<sup>+</sup> T cell activation and effector responsesEugene Y Chiang, Patricia E de Almeida, Denise E de Almeida Nagata, et al.Inorganic Chemistry|February 23, 2017
Reactivity Study of Unsymmetrical β-Diketiminato Copper(I) Complexes: Effect of the Chelating RingWan-Jung Chuang, Sung-Po Hsu, Kuldeep Chand, et al.Emerging Infectious Diseases|August 23, 2022
Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010-2016Jonathon R Campbell, Placide Nsengiyumva, Leslie Y Chiang, et al.Molecular Vision|December 23, 2008
Evaluation of LOXL1 polymorphisms in primary open-angle glaucoma in southern and northern ChineseWei Fen Gong, Sylvia W Y Chiang, Li Jia Chen, et al.Investigative Ophthalmology & Visual Science|April 19, 2008
Multiple gene polymorphisms in the complement factor h gene are associated with exudative age-related macular degeneration in chineseTsz Kin Ng, Li Jia Chen, David T L Liu, et al.ERJ Open Research|February 18, 2025
Activity behaviours and quality of life in patients with malignant pleural effusionBianca M Iacopetta, David C L Lam, Jenny C L Ngai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Partially mismatched related-donor bone marrow transplantation for pediatric patients with acute leukemia: younger donors and absence of peripheral blasts improve outcomeK T Godder, L J Hazlett, S H Abhyankar, et al.Immunity|March 9, 2022
Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8<sup>+</sup> T cell responsesKarl L Banta, Xiaozheng Xu, Avantika S Chitre, et al.Pageof 96